This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Therapeutic Drug Monitoring Markets

NEW YORK, March 25, 2013 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Therapeutic Drug Monitoring Markets

Therapeutic drug monitoring (TDM) is an important clinical assessment of drug plasma concentrations that also yields information regarding the efficacy, toxicity levels and potential drug-drug interactions of agents with a narrow therapeutic index. Ultimately, therapeutic drug monitoring testing provides clinical information to optimize dosage regimes and prevent adverse reactions and lack of treatment compliance.

This TriMark Publications report analyzes the therapeutic drug monitoring market and the various market segments within it, e.g., antiepileptics, antiarrhythmics, antibiotics, antineoplastics, bronchodilators, immunosuppressives and HIV/AIDS drugs. The report also examines drug analysis technology platforms, clinical applications of therapeutic drug testing and the market for quantitative diagnostic drug tests. Moreover, the study analyzes almost all of the companies known to be marketing, manufacturing or developing therapeutic drug monitoring products in the U.S. and worldwide. Detailed tables and charts with sales forecasts and marketshare data are also included.


1. Overview 9

1.1 Statement of Report 9

1.2 About This Report 9

1.3 Scope of the Report 10

1.4 Objectives 10

1.5 Methodology 11

1.6 Executive Summary 12

2. Therapeutic Drug Monitoring 162.1 Introduction 162.2 Function of Therapeutic Drug Monitoring 182.3 Drug Screening Boom 202.3.1 Pain Management Drug Testing in Europe 222.3.2 Neonate Patients and Patients of Old Age 222.3.3 Therapeutic Drug Monitoring and Immunosuppressive Drugs 232.3.4 Antiretroviral Usage and TDM Monitoring 232.4 The Process of Therapeutic Drug Monitoring 25

3. Commonly Monitored Therapeutic Drugs 29

3.1 Antiepileptics 30

3.2 Antiarrhythmics 32

3.3 Antimanics 35

3.4 Antineoplastic Drugs (Anticancer Drugs) 37

3.5 Bronchodilators 39

3.6 Antibiotics 40

3.7 Immunosupressants 41

3.7.1 Interference in Immunosuppressant Drug Immunoassays1 42

1 of 10

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,698.18 -77.94 -0.44%
S&P 500 2,059.69 -8.20 -0.40%
NASDAQ 4,880.2280 -20.6570 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs